On ECHEMI
Home > Drugs > Xiamen Amoytop Biotech Co., Ltd.
Xiamen Amoytop Biotech Co., Ltd.
  • Founded in:

    1996-08-07
  • Country:

    China China
  • Address:

    No. 330, Wengjiao Road, Xinyang Industrial Zone, Haicang, Xiamen
  • Tax NO.:

    913502002600603688
  • Registered Funds:

    406.8 million yuan
  • Website:

  • Email:

Related Drugs
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhGCSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhGCSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow, selectively acting on granulocyte hematopoietic progenitor cells, promoting their proliferation and differentiation, and increasing the function of granulocyte terminally differentiated cells.

More

This product is human granulocyte colony stimulating factor (rhGCSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhGCSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow, selectively acting on granulocyte hematopoietic progenitor cells, promoting their proliferation and differentiation, and increasing the function of granulocyte terminally differentiated cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhGCSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhGCSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow, selectively acting on granulocyte hematopoietic progenitor cells, promoting their proliferation and differentiation, and increasing the function of granulocyte terminally differentiated cells.

More

This product is human granulocyte colony stimulating factor (rhGCSF) produced by genetic recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhGCSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow, selectively acting on granulocyte hematopoietic progenitor cells, promoting their proliferation and differentiation, and increasing the function of granulocyte terminally differentiated cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Recombinant human granulocyte macrophage stimulating factor for injection
Main ingredients: recombinant human granulocyte macrophage colony stimulating factor
Name Description Content CAS NO. Registered Holders
GRANULOCYTE-MACROPHAGE COLONY- STIMULATI

It acts on hematopoietic progenitor cells, promotes their proliferation and differentiation, stimulates the maturation of granulocytes, mononuclear macrophages, promotes the release of mature cells into peripheral blood, and can promote the various functions of macrophages and eosinophils

More

It acts on hematopoietic progenitor cells, promotes their proliferation and differentiation, stimulates the maturation of granulocytes, mononuclear macrophages, promotes the release of mature cells into peripheral blood, and can promote the various functions of macrophages and eosinophils

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.